Village Farms International, Inc.
Village Farms International, Inc. Q4 FY2024 earnings call
March 13, 2025 · fiscal period ended 2024-12
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-03-13
Management highlights
Management Statement and Operational Highlights
- Financial Performance: Excluding the inventory impairment, Q4 was one of the strongest quarters in the past four years. Total Q4 revenues were $83 million, up 11% year-over-year, and full-year revenues were $336 million, up 18% year-over-year.
- Canadian Cannabis: Strong market share in Canada, moving to #2 in Pre-Roll and #6 in vapes nationally. Launched Super Toast all-in-one vapes, which became #6 nationally and #2 in Ontario. Took a $10.5 million non-cash write-down of suboptimal vape inventory. International medicinal exports in Q4 were up 113% year-over-year.
- Fresh Produce: Benefited from new cultivation technologies like AI and machine automation. Received $3.5 million in other income from vendor settlements related to the tomato brown rugose virus.
- International Cannabis: Q4 exports to international medical markets were up 113% year-over-year. Dutch operations: first harvest from Drachten facility, broke ground on Phase 2 cultivation facility in Groningen to quadruple production.
- Operational Updates: Optimizing Canadian cannabis resources for efficiency, refinancing fresh produce debt and cannabis debt, and discussing with Dutch lenders for Leli Holland operations.
Segment performance
Segment Performance
- Canadian Cannabis: Q4 net sales increased 10% year-over-year in Canadian dollars. Excluding the $10.5 million inventory write-down, adjusted EBITDA was positive. Retail branded sales were flat, while non-branded sales grew 20% year-over-year. International medicinal exports in Q4 were up 127% year-over-year in Canadian dollars. Excluding the inventory impairment, gross margin for Canadian cannabis would have been in the 30%-40% target range.
- Fresh Produce: Q4 sales were $43.3 million, up 17% year-over-year. Benefited from $3.5 million of other income related to vendor settlements from the tomato brown rugose virus. Adjusted EBITDA was $4.1 million, and net income was approximately $2 million.
- US Cannabis: Q4 revenues were $4.6 million, up 17% sequentially. Gross margin was 70%, and adjusted EBITDA was positive $300,000.
- Clean Energy: Ended 2024 on pace to deliver approximately $2 million in net income to consolidated results in 2025.
Guidance
Guidance
- Expect to triple international medicinal export sales in 2025.
- Phase 2 cultivation facility in the Netherlands is expected to be planted out in the fourth quarter of 2025, quadrupling annual production capabilities.
- Clean Energy is on track to deliver approximately $2 million in net income to consolidated results in 2025.
- Refinancing of produce debt and cannabis debt is in progress, with expectations to complete by specific deadlines.
Risks
Risks
- Tariff impacts on fresh produce sales if implemented, with potential to pass on 25% tariffs to customers.
- Potential power constraints for other operators in the Netherlands, but Village Farms has a 6 MW power supply.
- Regulatory risks in international markets, including changing deadlines for coffee shops in the Netherlands to buy 100% from licensed suppliers.
Q&A highlights
Question and Answer
Q: On inventory impairment impact on revenue and top-line, and branded sales commentary A: Inventory write-down didn't impact revenue. Branded sales were flat as the company moved away from lower tier products, but the launch of Super Toast vapes was successful.
Q: Allocation of product to Canada vs international, market share in Canada A: Canada is the foundation, not shortshipping, but focusing on profitable categories. Will hold/share selectively in profitable categories in Canada, with most incremental product going to international markets.
Q: Holland operations status, coffee shop buying, international growth route-to-market A: 7 licensed producers in the Netherlands, coffee shops to buy 100% from license holders by April 7th. International growth is a focus, but details on route-to-market weren't elaborated on the call.
Q: International sales growth guidance, split between Netherlands and other markets A: Tripling international medicinal export sales doesn't include the Netherlands (RAC segment).
Q: Canadian cannabis market oversupply risk A: Limited biomass in the Canadian market, and high-quality flower will have steady demand due to quality-driven consumer preferences
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $-0.08 | $-0.02 | -300.0% | $-0.08 |
| Revenue | $82.6M | $78.4M | +5.2% | $74.2M |
Transcript
March 13, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.